Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Boyar

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Molecular Pharmacology|June 1, 1988
Dopamine release and metabolism after chronic delivery of selective or nonselective dopamine autoreceptor agonistsC A Altar, B Berner, P Beall, et al.
The Journal of Biological Chemistry|May 30, 1998
Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxinZ Chen, X Zhang, N C Gonnella, et al.
Biochemistry|February 18, 1997
Analysis of hydroperoxide-induced tyrosyl radicals and lipoxygenase activity in aspirin-treated human prostaglandin H synthase-2G Xiao, A L Tsai, G Palmer, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 1, 1988
Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonistsC A Altar, W C Boyar, A Wasley, et al.
Protein Science : a Publication of the Protein Society|August 1, 1994
The pharmacophore of the human C5a anaphylatoxinM J Toth, L Huwyler, W C Boyar, et al.
European Journal of Pharmacology|April 7, 1987
Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-1B agonistR F Neale, S L Fallon, W C Boyar, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Molecular Pharmacology|June 1, 1988
Dopamine release and metabolism after chronic delivery of selective or nonselective dopamine autoreceptor agonistsC A Altar, B Berner, P Beall, et al.
The Journal of Biological Chemistry|May 30, 1998
Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxinZ Chen, X Zhang, N C Gonnella, et al.
Biochemistry|February 18, 1997
Analysis of hydroperoxide-induced tyrosyl radicals and lipoxygenase activity in aspirin-treated human prostaglandin H synthase-2G Xiao, A L Tsai, G Palmer, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 1, 1988
Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonistsC A Altar, W C Boyar, A Wasley, et al.
Protein Science : a Publication of the Protein Society|August 1, 1994
The pharmacophore of the human C5a anaphylatoxinM J Toth, L Huwyler, W C Boyar, et al.
European Journal of Pharmacology|April 7, 1987
Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-1B agonistR F Neale, S L Fallon, W C Boyar, et al.
Pageof 2